The current valuation score of Mereo BioPharma Group PLC is 7.02, ranking 270 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.33, which is -32.28% below the recent high of -0.90 and -6789.08% above the recent low of -91.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.